CYTK - Cytokinetics, Incorporated
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$109.91
DETAILS
HIGH:
$140.00
LOW:
$84.00
MEDIAN:
$112.00
CONSENSUS:
$109.91
UPSIDE:
51.14%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Cooperman | 1,048,103 | $89.3M | 0.0% | +1,007,403 | INCREASED |
| Greenblatt | 5,367 | $457,215 | 0.0% | +5,367 | NEW |
| Wood | 600 | $51,114 | 0.0% | -6,300 | DECREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-09-01 | PARSHALL B LYNNE | director | SELL | 5,000 | $71.48 | $357K |
| 2026-08-31 | Callos Andrew | officer: EVP, Chief Commercial Officer | SELL | 10,000 | $70.24 | $702K |
| 2026-08-31 | Callos Andrew | officer: EVP, Chief Commercial Officer | M-Exempt | 10,000 | $23.26 | $233K |
| 2026-08-31 | Blum Robert I | director, officer: President & CEO | SELL | 7,500 | $70.24 | $527K |
| 2026-08-31 | Blum Robert I | director, officer: President & CEO | M-Exempt | 7,500 | $10.60 | $80K |
| 2026-08-18 | Malik Fady Ibraham | officer: EVP Research & Development | M-Exempt | 3,500 | $7.80 | $27K |
| 2026-08-18 | Malik Fady Ibraham | officer: EVP Research & Development | SELL | 3,500 | $75.82 | $265K |
| 2026-08-10 | Blum Robert I | director, officer: President & CEO | M-Exempt | 7,500 | $10.60 | $80K |
| 2026-08-10 | Blum Robert I | director, officer: President & CEO | SELL | 7,500 | $76.76 | $576K |
| 2026-07-30 | Callos Andrew | officer: EVP, Chief Commercial Officer | SELL | 14,000 | $79.88 | $1.1M |
| 2026-07-30 | Callos Andrew | officer: EVP, Chief Commercial Officer | M-Exempt | 14,000 | $23.26 | $326K |
| 2026-07-27 | Blum Robert I | director, officer: President & CEO | M-Exempt | 7,500 | $10.60 | $80K |
| 2026-07-27 | Blum Robert I | director, officer: President & CEO | SELL | 7,500 | $80.87 | $607K |
| 2026-07-21 | Malik Fady Ibraham | officer: EVP Research & Development | SELL | 3,500 | $80.59 | $282K |
| 2026-07-21 | Malik Fady Ibraham | officer: EVP Research & Development | M-Exempt | 3,500 | $7.80 | $27K |
| 2026-07-15 | Daly James M | director | A-Award | 151 | $82.62 | $12K |
| 2026-07-15 | Kaye Edward M. MD | director | A-Award | 151 | $82.62 | $12K |
| 2026-07-15 | HENDERSON JOHN T | director | A-Award | 272 | $82.62 | $22K |
| 2026-07-15 | Harrington Robert Arthur | director | A-Award | 151 | $82.62 | $12K |
| 2026-07-15 | Wysenski Nancy | director | A-Award | 75 | $82.62 | $6K |
| 2026-07-15 | WIERENGA WENDELL | director | A-Award | 75 | $82.62 | $6K |
| 2026-07-13 | Blum Robert I | director, officer: President & CEO | M-Exempt | 7,490 | $10.60 | $79K |
| 2026-07-13 | Blum Robert I | director, officer: President & CEO | SELL | 7,490 | $82.02 | $614K |
| 2026-07-07 | Malik Fady Ibraham | officer: EVP Research & Development | SELL | 3,500 | $86.62 | $303K |
| 2026-07-07 | Malik Fady Ibraham | officer: EVP Research & Development | M-Exempt | 3,500 | $7.80 | $27K |
Congressional Trading
| DATE | MEMBER | CHAMBER | TYPE | AMOUNT |
|---|---|---|---|---|
| 2026-07-03 | Gilbert Cisneros | HOUSE | Purchase | $1,001 - $15,000 |